Lv5
1310 积分 2020-08-12 加入
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML
2天前
待确认
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias
2天前
已完结
HLA‐B*38:165N and HLA‐B*51:309 alleles identified in two Chinese cervical intraepithelial neoplasia patients
4天前
已完结
Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML
4天前
已完结
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML
10天前
已关闭
Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia
10天前
已完结
BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia
11天前
已完结
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML
14天前
已完结
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Can Be Treated with Chemotherapy-Free Regimens without Transplant
20天前
已完结
An update on mixed phenotype acute leukemia
20天前
已完结
皖公网安备34019202002308
